• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作者更正:PAK信号传导驱动BRAF突变型黑色素瘤对MAPK抑制剂产生获得性耐药。

Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.

作者信息

Lu Hezhe, Liu Shujing, Zhang Gao, Wu Bin, Zhu Yueyao, Frederick Dennie T, Hu Yi, Zhong Wenqun, Randell Sergio, Sadek Norah, Zhang Wei, Chen Gang, Cheng Chaoran, Zeng Jingwen, Wu Lawrence W, Zhang Jie, Liu Xiaoming, Xu Wei, Krepler Clemens, Sproesser Katrin, Xiao Min, Miao Benchun, Liu Jianglan, Song Claire D, Liu Jephrey Y, Karakousis Giorgos C, Schuchter Lynn M, Lu Yiling, Mills Gordon, Cong Yusheng, Chernoff Jonathan, Guo Jun, Boland Genevieve M, Sullivan Ryan J, Wei Zhi, Field Jeffrey, Amaravadi Ravi K, Flaherty Keith T, Herlyn Meenhard, Xu Xiaowei, Guo Wei

机构信息

Department of Biology, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA.

Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA.

出版信息

Nature. 2019 Jan;565(7738):E4. doi: 10.1038/s41586-018-0814-7.

DOI:
10.1038/s41586-018-0814-7
PMID:30532003
Abstract

In this Letter, two relevant references were omitted; see the accompanying Amendment for details. The original Letter has not been corrected.

摘要

在这封信中,遗漏了两个相关参考文献;详情见随附的勘误表。原始信件未作更正。

相似文献

1
Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.作者更正:PAK信号传导驱动BRAF突变型黑色素瘤对MAPK抑制剂产生获得性耐药。
Nature. 2019 Jan;565(7738):E4. doi: 10.1038/s41586-018-0814-7.
2
Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma.核糖体蛋白 S6 磷酸化的异常调节赋予 BRAF 突变型黑色素瘤对 MAPK 通路抑制剂的获得性耐药。
Acta Pharmacol Sin. 2019 Feb;40(2):268-278. doi: 10.1038/s41401-018-0020-z. Epub 2018 May 18.
3
Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations.BRAF 突变型结直肠癌中通过 MAPK 通路改变对 RAF 抑制剂联合治疗产生临床获得性耐药
Cancer Discov. 2015 Apr;5(4):358-67. doi: 10.1158/2159-8290.CD-14-1518. Epub 2015 Feb 11.
4
Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase BRAF-mutant lung cancer.一种可避免在蛋白激酶BRAF突变型肺癌中出现矛盾的MAPK通路激活的RAF抑制剂的临床前疗效。
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13456-13461. doi: 10.1073/pnas.1610456113. Epub 2016 Nov 9.
5
Author Correction: EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors.作者更正:EZH2抑制使BRG1和EGFR突变型肺肿瘤对拓扑异构酶II抑制剂敏感。
Nature. 2018 Nov;563(7732):E27. doi: 10.1038/s41586-018-0580-6.
6
Dual Inhibition of MAPK and JAK2/STAT3 Pathways Is Critical for the Treatment of BRAF Mutant Melanoma.丝裂原活化蛋白激酶(MAPK)和Janus激酶2/信号转导和转录激活因子3(JAK2/STAT3)通路的双重抑制对BRAF突变型黑色素瘤的治疗至关重要。
Mol Ther Oncolytics. 2020 Jun 5;18:100-108. doi: 10.1016/j.omto.2020.06.004. eCollection 2020 Sep 25.
7
HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma.组蛋白去乙酰化酶抑制剂通过改变黑色素瘤亚群中的 PI3K 和存活信号来恢复 BRAF 抑制剂的敏感性。
Int J Cancer. 2018 May 1;142(9):1926-1937. doi: 10.1002/ijc.31199. Epub 2017 Dec 20.
8
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer.BRAF 突变型结直肠癌中对靶向治疗联合方案获得性耐药的分子图谱
Cancer Res. 2016 Aug 1;76(15):4504-15. doi: 10.1158/0008-5472.CAN-16-0396. Epub 2016 Jun 16.
9
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers.作者更正:HER2和HER3突变型癌症患者中的HER激酶抑制作用
Nature. 2019 Feb;566(7745):E11-E12. doi: 10.1038/s41586-019-0974-0.
10
Author Correction: Enhancer decommissioning by LSD1 during embryonic stem cell differentiation.作者更正:胚胎干细胞分化过程中LSD1介导的增强子失活
Nature. 2018 Oct;562(7728):E24. doi: 10.1038/s41586-018-0487-2.

引用本文的文献

1
Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine.金纳米颗粒使胰腺癌细胞对吉西他滨敏感。
Cell Stress. 2019 Jul 31;3(8):267-279. doi: 10.15698/cst2019.08.195.